PIPERACIL-TAZOBACT 3.375 GM VL
PIPERACIL-TAZOBACT 3.375 GM VL, a generic antibiotic with a $3.07 acquisition cost, typically shows substantial pricing variation between acquisition cost and hospital billing rates.
About the analyst
David Park researches procedure pricing and insurance reimbursement patterns at BillRazor Research. He specializes in cost comparison across care settings and metropolitan areas. Expertise: procedure pricing, insurance reimbursement, cost comparison.
PIPERACIL-TAZOBACT is a generic antibiotic combination used to treat serious bacterial infections in hospital settings. This medication typically appears on inpatient claims with charges that can vary significantly between facilities, often showing differences of several hundred dollars per vial depending on the healthcare setting.
No credit card required. Results in 60 seconds.
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.